|Title of Law:||Muscular Dystrophy Community Assistance, Research and Education Amendments of 2001 (MD-CARE Act)|
|Law #:||Public Law 107- 84|
|Passed by Congress:||107th Congress (1st Session)|
The following are excerpts from the final legislation and/or conference
report which contain National Academies' studies. (Pound signs [##]
between passages denote the deletion of unrelated text.)
HR717 Wicker (R-Miss.) 11/29/01
Enrolled (finally passed both houses)
To amend the Public Health Service Act to provide for research with
respect to various forms of muscular dystrophy, including Duchenne,
Becker, limb girdle, congenital, facioscapulohumeral, myotonic,
oculopharyngeal, distal, and Emery-Dreifuss muscular dystrophies.
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- ---
SEC. 7. STUDY ON THE USE OF CENTERS OF EXCELLENCE AT THE NATIONAL
INSTITUTES OF HEALTH.
(a) REVIEW.-Not later than 60 days after the date of enactment of this
Act, the Secretary of Health and Human Services shall enter into a
contract with the Institute of Medicine for the purpose of conducting a
study and making recommendations on the impact of, need for, and other
issues associated with Centers of Excellence at the National Institutes of
(b) AREAS OF REVIEW.-In conducting the study under subsection (a), the
Institute of Medicine shall at a minimum consider the following:
(1) The current areas of research incorporating Centers of
Excellence (which shall include a description of such areas) and the
relationship of this form of funding mechanism to other forms of funding
for research grants, including investigator initiated research, contracts
and other types of research support awards.
(2) The distinctive aspects of Centers of Excellence, including the
additional knowledge that may be expected to be gained through Centers of
Excellence as compared to other forms of grant or contract mechanisms.
(3) The costs associated with establishing and maintaining Centers
of Excellence, and the record of scholarship and training resulting from
such Centers. The research and training contributions of Centers should be
assessed on their own merits and in comparison with other forms of
(4) Specific areas of research in which Centers of Excellence may be
useful, needed, or underused, as well as areas of research in which
Centers of Excellence may not be helpful.
(5) Criteria that may be applied in determining when Centers of
Excellence are an appropriate and cost-effective research investment and
conditions that should be present in order to consider the establishment
of Centers of Excellence.
(6) Alternative research models that may accomplish results similar
to or greater than Centers of Excellence.
(c) REPORT.-Not later than 1 year after the date on which the contract is
entered into under subsection (a), the Institute of Medicine shall
complete the study under such subsection and submit a report to the
Secretary of Health and Human Services and the appropriate committees of
Congress that contains the results of such study.